Welcome to our dedicated page for Innospec SEC filings (Ticker: IOSP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Innospec Inc. (NASDAQ: IOSP), an international specialty chemicals company. These documents offer detailed information about the company’s operations across its Performance Chemicals, Fuel Specialties and Oilfield Services segments, as well as its capital structure and governance.
Innospec’s SEC filings include periodic reports such as annual reports on Form 10-K and quarterly reports on Form 10-Q, which present audited or reviewed financial statements, segmental data and discussions of results. Investors use these filings to examine net sales, gross profit and operating income by segment, along with notes on research and development, corporate costs and regional performance.
The company also files current reports on Form 8-K to disclose material events. Recent 8-K filings have covered the release of quarterly financial results and the declaration of semi-annual dividends on IOSP common stock. These filings identify the NASDAQ listing for Innospec’s common shares and provide details such as record and payment dates for dividends.
On Stock Titan, Innospec’s filings are updated as they are released on EDGAR, and AI-powered summaries can help explain the key points in lengthy documents. Users can quickly see which items relate to earnings, dividend actions, segment performance or other notable events. For those interested in topics such as non-GAAP measures, net cash, or segment trends in Performance Chemicals, Fuel Specialties and Oilfield Services, the filings page offers a structured way to review the company’s regulatory disclosures.
By combining real-time access to IOSP filings with AI-generated highlights, this page helps readers navigate Innospec’s official reporting without needing to read every line of each document.
INNOSPEC INC. senior vice president Corbin Barnes reported an equity award in company stock. On February 16, 2026, he acquired 1,730 shares of common stock at a stated price of $0.00 per share through the settlement of a performance-based restricted stock unit award granted on February 27, 2023.
After this grant, Barnes directly holds a total of 10,764.6117 shares of Innospec common stock. The transaction reflects equity compensation rather than an open-market purchase or sale.
Innospec Inc. senior vice president of human resources Hardy Louis Griffin III acquired 1,299 shares of common stock through a grant/award on settlement of a performance-based restricted stock unit granted on February 27, 2023. Following this award, his direct ownership stands at 8,041 common shares.
Innospec Inc. EVP & CFO Ian Cleminson acquired 2,380 shares of common stock on 2026-02-16 through the settlement of a performance-based restricted stock unit award. The RSU award was originally granted on 2023-02-27. After this grant, his directly held common stock position increased to 18,238 shares.
Innospec Inc. President and CEO Patrick Williams reported an acquisition of company shares through an equity award. On February 16, he received 18,966 shares of common stock at no cash price upon settlement of a performance-based restricted stock unit grant originally awarded on February 27, 2023. Following this grant, his direct holdings increased to 218,655 common shares.
INNOSPEC INC. senior vice president, general counsel and chief compliance officer David B. Jones acquired 1,903 shares of common stock on February 16, 2026 through the settlement of a performance-based restricted stock unit award originally granted on February 27, 2023. The award carried no cash purchase price per share. Following this equity grant, Jones directly holds a total of 13,603 shares of Innospec common stock.
Innospec Inc. reports full-year 2025 results, with net sales of $1,778.0 million, down 4% from 2024 as lower Oilfield Services revenue offset modest growth in Performance Chemicals.
Net income rose to $116.6 million from $35.6 million, helped by the absence of a prior-year pension settlement charge. Fuel Specialties delivered 12% higher operating income on stronger mix and pricing, while Performance Chemicals and Oilfield Services saw margin pressure and, in 2025, asset and intangible impairments. Cash and cash equivalents were $292.5 million with no debt, and cash from operations after capital expenditures was $63.9 million. The company paid dividends of $1.71 per share and repurchased 264,000 shares for $23.9 million.
Innospec Inc. reported mixed fourth-quarter and full-year 2025 results, with solid profitability but lower sales and underlying earnings. Fourth-quarter revenue was $455.6 million, down 2%, while net income swung to a profit of $47.4 million, or $1.91 per diluted share, compared with a prior-year loss driven by a UK pension buyout charge. Adjusted non-GAAP EPS rose to $1.50 from $1.41, and adjusted EBITDA was essentially flat at $55.7 million.
For 2025, revenue declined 4% to $1.78 billion and adjusted EBITDA fell 10% to $203.0 million. Full-year net income improved to $116.6 million, or $4.67 per diluted share, largely reflecting the absence of the prior-year UK pension scheme settlement. However, adjusted non-GAAP EPS decreased to $5.27 from $5.92, showing softer underlying performance.
Fuel Specialties was a bright spot, with 2025 operating income up 12% to $144.8 million, while Performance Chemicals and Oilfield Services saw lower annual operating income. Cash generation remained strong: operating cash flow was $138.3 million for the year, and Innospec ended 2025 with net cash of $292.5 million, giving it balance sheet flexibility for dividends, buybacks, investment and M&A.
Innospec Inc. director reports open-market stock purchase
A director of Innospec Inc. (IOSP) reported buying 340 shares of the company’s common stock on 11/14/2025 at a price of $74.09 per share. After this transaction, the director beneficially owns 5,837 shares, held as a direct ownership position. The transaction was reported on a Form 4 as a purchase coded "P" in the non-derivative securities table, and no derivative security transactions were reported.
Innospec Inc. (IOSP) reported third-quarter 2025 results. Net sales were $441.9 million versus $443.4 million a year ago. Operating income fell to $5.9 million from $45.6 million, and net income was $12.9 million, or $0.52 diluted EPS, compared with $33.4 million, or $1.33 diluted EPS.
Segment trends were mixed. Performance Chemicals sales rose 4% to $170.8 million but gross margin declined to 15.1% on pricing erosion and mix. Fuel Specialties grew 4% to $172.0 million with gross margin up to 35.6% on improved mix and disciplined pricing. Oilfield Services declined 13% to $99.1 million, while gross margin improved to 30.0% on mix.
Results included a $22.9 million impairment of property, plant and equipment and a $19.1 million impairment of intangible assets, partly offset by a $17.7 million credit from contingent consideration revaluation. Cash and cash equivalents were $270.8 million with no borrowings on the $250.0 million revolver. Year-to-date operating cash flow was $76.9 million; the company paid dividends of $20.8 million and repurchased $23.9 million of common stock. Shares outstanding were 24,777,582 as of October 31, 2025.
Innospec Inc. reported that it issued a press release announcing its financial results for the fiscal quarter ended September 30, 2025. The company also declared a semi-annual dividend of $0.87 per share on its common stock.
The dividend will be paid on November 26, 2025 to shareholders of record as of November 18, 2025. The press release was furnished as Exhibit 99.1, providing details on the quarter’s performance.